Laura Maffei

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Luspatercept in β-thalassemia: Who and when. Strengths and weaknesses points of a real-world evidence.

Luspatercept in β-thalassemia: Who and when. Strengths and weaknesses points of a real-world evidence.

Journal: EJHaem

Published: September 18, 2024

Hemorheological profiles and chronic inflammation markers in transfusion-dependent and non-transfusion- dependent thalassemia.

Hemorheological profiles and chronic inflammation markers in transfusion-dependent and non-transfusion- dependent thalassemia.

Journal: Frontiers in molecular biosciences

Published: November 26, 2022

Epidemiological Surveillance of SARSCov2 in β-Thalassemia Patients in the Last Two Years: Reinfection Rate, Insights and Future Challenges.

Epidemiological Surveillance of SARSCov2 in β-Thalassemia Patients in the Last Two Years: Reinfection Rate, Insights and Future Challenges.

Journal: Mediterranean journal of hematology and infectious diseases

Published: July 18, 2022

Differential diagnosis of hereditary hemolytic anemias in a single multiscreening test by TGA/chemometrics.

Differential diagnosis of hereditary hemolytic anemias in a single multiscreening test by TGA/chemometrics.

Journal: Chemical communications (Cambridge, England)

Published: June 20, 2020

Impact of SARS CoV-2 in Hemoglobinopathies with Immune Disfunction and Epidemiology. A Protective Mechanism from Beta Chain Hemoglobin Defects?

Impact of SARS CoV-2 in Hemoglobinopathies with Immune Disfunction and Epidemiology. A Protective Mechanism from Beta Chain Hemoglobin Defects?

Journal: Mediterranean journal of hematology and infectious diseases

Published: June 09, 2020

An Innovative Multilevel Test for Hemoglobinopathies: TGA/Chemometrics Simultaneously Identifies and Classifies Sickle Cell Disease From Thalassemia.

An Innovative Multilevel Test for Hemoglobinopathies: TGA/Chemometrics Simultaneously Identifies and Classifies Sickle Cell Disease From Thalassemia.

Journal: Frontiers in molecular biosciences

Published: April 07, 2020

Innovative screening test for the early detection of sickle cell anemia.

Innovative screening test for the early detection of sickle cell anemia.

Journal: Talanta

Published: February 10, 2020

Phenotypical and functional abnormalities of circulating neutrophils in patients with β-thalassemia.

Phenotypical and functional abnormalities of circulating neutrophils in patients with β-thalassemia.

Journal: Annals of hematology

Published: October 31, 2019

Platelet and megakaryocyte CD40L expression in β-Thalassemic patients.

Platelet and megakaryocyte CD40L expression in β-Thalassemic patients.

Journal: Thrombosis research

Published: October 24, 2019

Hemorheological Alterations and Oxidative Damage in Sickle Cell Anemia.

Hemorheological Alterations and Oxidative Damage in Sickle Cell Anemia.

Journal: Frontiers in molecular biosciences

Published: September 16, 2019

HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives.

HCV Infection in Thalassemia Syndromes and Hemoglobinopathies: New Perspectives.

Journal: Frontiers in molecular biosciences

Published: August 17, 2019

Pregnancy in Thalassemia and Sickle Cell Disease: The Experience of an Italian Thalassemia Center.

Pregnancy in Thalassemia and Sickle Cell Disease: The Experience of an Italian Thalassemia Center.

Journal: Frontiers in molecular biosciences

Published: August 13, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026